An anti-tuberculosis compound screen using a zebrafish infection model identifies an aspartyl-tRNA synthetase inhibitor
Eva Habjan(Amsterdam UMC Location Vrije Universiteit Amsterdam), Alexander Speer(Amsterdam University Medical Centers), Gunny van Stempvoort, Wilbert Bitter(Vrije Universiteit Amsterdam), Kin Ki Jim(Academic Medical Center), Vien Q. T. Ho(Amsterdam University Medical Centers), Daan P. Geerke(Vrije Universiteit Amsterdam), Coenraad Kuijl(The Netherlands Cancer Institute), James Gallant(Amsterdam University Medical Centers)
Cited by 29
Related Papers
Type VII secretion — mycobacteria show the way
|Nature Reviews Microbiology|2007|768
Phagosomal Rupture by Mycobacterium tuberculosis Results in Toxicity and Host Cell Death
|PLoS Pathogens|2012|567
Expression analysis of the Toll-like receptor and TIR domain adaptor families of zebrafish
|Molecular Immunology|2003|519
ESX‐1‐mediated translocation to the cytosol controls virulence of mycobacteria
|Cellular Microbiology|2012|421
Towards a new combination therapy for tuberculosis with next generation benzothiazinones
|EMBO Molecular Medicine|2014|388